Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients.

Mustafa, Gul M; Larry, Denner; Petersen, John R; Elferink, Cornelis J

Mustafa, Gul M; Larry, Denner; Petersen, John R; Elferink, Cornelis J.

Afiliação

Mustafa GM; Gul M Mustafa, Cornelis J Elferink, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555-0654, United States.
Larry D; Gul M Mustafa, Cornelis J Elferink, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555-0654, United States.
Petersen JR; Gul M Mustafa, Cornelis J Elferink, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555-0654, United States.
Elferink CJ; Gul M Mustafa, Cornelis J Elferink, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555-0654, United States.

World J Hepatol ; 7(10): 1312-24, 2015 Jun 08.

Article em En | MEDLINE | ID: mdl-26052377

Palavras-chave

Biomarkers; Early detection; Hepatocellular carcinoma; Selected reaction monitoring; Targeted proteomics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Revista: World J Hepatol Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google